The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 27, 2008
Filed:
Dec. 17, 2004
Guixue Yu, Princeton Junction, NJ (US);
William R. Ewing, Yardley, PA (US);
Amarendra B. Mikkilineni, Easton, PA (US);
Annapurna Pendri, Glastonbury, CT (US);
Philip M. Sher, Plainsboro, NJ (US);
Samuel Gerritz, Guilford, CT (US);
Bruce A. Ellsworth, Princeton, NJ (US);
Gang Wu, Princeton, NJ (US);
Yanting Huang, Pennington, NJ (US);
Chongqing Sun, East Windsor, NJ (US);
Natesan Murugesan, Princeton Junction, NJ (US);
Zhengxiang Gu, Princeton, NJ (US);
Ying Wang, Princeton, NJ (US);
Doree Sitkoff, Dresher, PA (US);
Stephen R. Johnson, Erdenheim, PA (US);
Ximao Wu, Princeton Junction, NJ (US);
Guixue Yu, Princeton Junction, NJ (US);
William R. Ewing, Yardley, PA (US);
Amarendra B. Mikkilineni, Easton, PA (US);
Annapurna Pendri, Glastonbury, CT (US);
Philip M. Sher, Plainsboro, NJ (US);
Samuel Gerritz, Guilford, CT (US);
Bruce A. Ellsworth, Princeton, NJ (US);
Gang Wu, Princeton, NJ (US);
Yanting Huang, Pennington, NJ (US);
Chongqing Sun, East Windsor, NJ (US);
Natesan Murugesan, Princeton Junction, NJ (US);
Zhengxiang Gu, Princeton, NJ (US);
Ying Wang, Princeton, NJ (US);
Doree Sitkoff, Dresher, PA (US);
Stephen R. Johnson, Erdenheim, PA (US);
Ximao Wu, Princeton Junction, NJ (US);
Bristol-Myers Squibb Company, Princeton, NJ (US);
Abstract
The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the general Formula I: including all prodrugs, pharmaceutically acceptable salts and stereoisomers, R, R, R, R, R, m and n are described herein.